Genetic and antigenic characterization of Canadian invasive Neisseria meningitidis serogroup C (MenC) case isolates in the post-MenC conjugate vaccine era, 2009–2013

References

1. Abdillahi H., Poolman J. T. 1987; Whole-cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 48:367–371 [View Article]
   [Google Scholar]
2. Ashton F. E., Ryan J. A., Borczyk A., Caugant D. A., Mancino L., Huang D. 1991; Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada. J Clin Microbiol 29:2489–2493[PubMed]
   [Google Scholar]
3. Caugant D. A., Bøvre K., Gaustad P., Bryn K., Holten E., Høiby E. A., Frøholm L. O. 1986; Multilocus genotypes determined by enzyme electrophoresis of Neisseria meningitidis isolated from patients with systemic disease and from healthy carriers. J Gen Microbiol 132:641–652[PubMed]
   [Google Scholar]
4. Claus H., Elias J., Meinhardt C., Frosch M., Vogel U. 2007; Deletion of the meningococcal fetA gene used for antigen sequence typing of invasive and commensal isolates from Germany: frequencies and mechanisms. J Clin Microbiol 45:2960–2964 [View Article][PubMed]
   [Google Scholar]
5. De Wals P., Deceuninck G., Lefebvre B., Boulianne N., De Serres G. 2011; Effectiveness of serogroup C meningococcal conjugate vaccine: a 7-year follow-up in Quebec, Canada. Pediatr Infect Dis J 30:566–569 [View Article][PubMed]
   [Google Scholar]
6. Elias J., Vogel U. 2007; IS1301 fingerprint analysis of Neisseria meningitidis strains belonging to the ET-15 clone. J Clin Microbiol 45:159–167 [View Article][PubMed]
   [Google Scholar]
7. Frasch C. E., Zollinger W. D., Poolman J. T. 1985; Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev Infect Dis 7:504–510 [View Article][PubMed]
   [Google Scholar]
8. Harrison O. B., Brueggemann A. B., Caugant D. A., van der Ende A., Frosch M., Gray S., Heuberger S., Krizova P., Olcen P. et al. 2011; Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review. Microbiology 157:2181–2195 [View Article][PubMed]
   [Google Scholar]
9. Hill A. B. 1977 A Short Textbook of Medical Statistics London: Hodder & Stoughton;
   [Google Scholar]
10. Hong E., Giorgini D., Deghmane A. E., Taha M. K. 2012; Functional impacts of the diversity of the meningococcal factor H binding protein. Vaccine 31:183–189 [View Article][PubMed]
    [Google Scholar]
11. Jamieson F. B., Rawte P., Deeks S. L., Zhou J., Law D. K. S., Deng S., Tsang R. S. W. 2013; Genetic and antigenic characterization of invasive endemic serogroup B Neisseria meningitidis from Ontario, Canada, in 2001–2010. J Med Microbiol 62:46–55 [View Article][PubMed]
    [Google Scholar]
12. Jelfs J., Munro R., Ashton F. E., Caugant D. A. 2000; Genetic characterization of a new variant within the ET-37 complex of Neisseria meningitidis associated with outbreaks in various parts of the world. Epidemiol Infect 125:285–298 [View Article][PubMed]
    [Google Scholar]
13. Kinlin L. M., Jamieson F., Brown E. M., Brown S., Rawte P., Dolman S., Drews S. J., Fisman D. N. 2009; Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000–2006. Vaccine 27:1735–1740 [View Article][PubMed]
    [Google Scholar]
14. Law D. K. S., Stoltz J., Henderson A. M., Tsang R. S. W. 2005; Antigenic and genetic characterization of serogroup C meningococci isolated from invasive meningococcal disease cases in Canada from 1999 to 2003. Can J Microbiol 51:523–530 [View Article][PubMed]
    [Google Scholar]
15. Law D. K. S., Zhou J., Deng S., Hoang L., Tyrrell G., Horsman G., Wylie J., Tsang R. S. W. 2014; Determination of serotyping antigens, clonal analysis and genetic characterization of the 4CMenB vaccine antigen genes in invasive Neisseria meningitidis from western Canada, 2009 to 2013. J Med Microbiol 63:1490–1499 [View Article][PubMed]
    [Google Scholar]
16. Li Y. A., Tsang R., Desai S., Deehan H. 2014; Enhanced surveillance of invasive meningococcal disease in Canada, 2006–2011. Can Commun Dis Rep 40:160–169
    [Google Scholar]
17. Lucidarme J., Comanducci M., Findlow J., Gray S. J., Kaczmarski E. B., Guiver M., Vallely P. J., Oster P., Pizza M. et al. 2010; Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine. Clin Vaccine Immunol 17:919–929 [View Article][PubMed]
    [Google Scholar]
18. Lucidarme J., Tan L., Exley R. M., Findlow J., Borrow R., Tang C. M. 2011; Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein. Clin Vaccine Immunol 18:1002–1014 [View Article][PubMed]
    [Google Scholar]
19. Maiden M. C. J., Bygraves J. A., Feil E., Morelli G., Russell J. E., Urwin R., Zhang Q., Zhou J., Zurth K. et al. 1998; Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95:3140–3145 [View Article][PubMed]
    [Google Scholar]
20. Marsh J. W., O’Leary M. M., Shutt K. A., Harrison L. H. 2007; Deletion of fetA gene sequences in serogroup B and C Neisseria meningitidis isolates. J Clin Microbiol 45:1333–1335 [View Article][PubMed]
    [Google Scholar]
21. NACI 2013; An Advisory Committee Statement (ACS) update on the use of quadrivalent conjugate meningococcal vaccines. Can Commun Dis Rep 39:1–40 [View Article]
    [Google Scholar]
22. Pollard A. J., Tam T. W. S.National Immunization Committee on Immunization 2011; An Advisory Committee Statement on the recommended use of meningococcal vaccines. Can Commun Dis Rep 27:2–36
    [Google Scholar]
23. Richmond P. C., Marshall H. S., Nissen M. D., Jiang Q., Jansen K. U., Garcés-Sánchez M., Martinón-Torres F., Beeslaar J., Szenborn L. et al. 2012; Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis 12:597–607 [View Article][PubMed]
    [Google Scholar]
24. Rosenstein N. E., Perkins B. A., Stephens D. S., Popovic T., Hughes J. M. 2001; Meningococcal disease. N Engl J Med 344:1378–1388 [View Article][PubMed]
    [Google Scholar]
25. Santolaya M. E., O’Ryan M. L., Valenzuela M. T., Prado V., Vergara R., Muñoz A., Toneatto D., Graña G., Wang H. et al. 2012; Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study. Lancet 379:617–624 [View Article][PubMed]
    [Google Scholar]
26. Sloan A. M., Henderson A. M., Tsang R. S. W. 2008; Characterization of serogroup A Neisseria meningitidis from invasive meningococcal disease cases in Canada between 1979 and 2006: epidemiological links to returning travellers. Can J Infect Dis Med Microbiol 19:227–232[PubMed]
    [Google Scholar]
27. Vogel U., Claus H., Frosch M., Caugant D. A. 2000; Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis.. J Clin Microbiol 38:941–942[PubMed]
    [Google Scholar]
28. Zhou J., Jamieson F., Dolman S., Hoang L. M., Rawte P., Tsang R. S. W. 2012a; Genetic and antigenic analysis of invasive serogroup C Neisseria meningitidis in Canada: a decrease in the electrophoretic type (ET)-15 clonal type and an increase in the proportion of isolates belonging to the ET-37 (but not ET-15) clonal type during the period from 2002 to 2009. Can J Infect Dis Med Microbiol 23:e55–e59[PubMed]
    [Google Scholar]
29. Zhou J., Lefebvre B., Deng S., Gilca R., Deceuninck G., Law D. K. S., De Wals P., Tsang R. S. W. 2012b; Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003. J Clin Microbiol 50:1545–1551 [View Article][PubMed]
    [Google Scholar]